Stay updated on Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a Locations section with New Jersey as a study site (New Brunswick, New Jersey).
    Difference
    0.2%
    Check dated 2025-12-23T21:31:31.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    PubMed publications section wording updated to indicate that publications are auto-filled from PubMed, replacing the previous description. The revision tag was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:21:03.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Deleted the general operating status notice about a lapse in government funding that could affect updates; this does not change trial data or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:48:41.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The newer screenshot shows added results sections (e.g., adverse events, response and survival metrics) and expanded study plan/eligibility criteria for the trial.
    Difference
    0.4%
    Check dated 2025-11-03T20:36:25.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    3%
    Check dated 2025-10-06T04:35:54.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    Update to v3.1.0; removal of two specific medical condition entries (Head and neck squamous cell carcinoma and Melanoma, Cutaneous Malignant) from the page.
    Difference
    0.3%
    Check dated 2025-09-29T01:30:51.000Z thumbnail image

Stay in the know with updates to Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.